Q2052 HCPCS code: Services, supplies and accessories used in the home for the administration of intravenous immune globulin (IVIG)
Q2052 is the HCPCS Level II code for services, supplies and accessories used in the home for the administration of intravenous immune globulin (IVIG). In 2024 Medicare paid an average of $27.13 per service for Q2052 across 380,140 services. Its Medicare coverage code is D (Special coverage instructions apply): Medicare covers it when its national or local coverage criteria are met. Medicare volume rose 1772% from 2022 to 2024 (20,306 to 380,140 services). In 2024, 349 suppliers billed Medicare for Q2052 (purchases), serving 2,988 beneficiaries; Florida, California, Texas accounted for 26% of services.
Code details
| Field | Value |
|---|---|
| Section | Q codes — Temporary codes |
| Coverage code | D — Special coverage instructions apply |
| Pricing indicator | 57 |
| BETOS category | O1E — Other drugs |
| Added | 2014-04-01 |
| Last action effective | 2023-07-01 |
Who bills Q2052 (2024)
| Measure | Value |
|---|---|
| Suppliers billing rentals | — |
| Suppliers billing purchases | 349 |
| Referring clinicians | 1,705 |
| Medicare beneficiaries | 2,988 |
| States with claims | 48 |
| Share of services in top 3 states (Florida, California, Texas) | 26% |
| Year | Suppliers | Beneficiaries |
|---|---|---|
| 2022 | 243 | 1,836 |
| 2023 | 234 | 1,939 |
| 2024 | 349 | 2,988 |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for Q2052, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 20,306 | 1,836 | $391.93 | $309.16 |
| 2023 | 22,085 | 1,939 | $407.75 | $319.42 |
| 2024 | 380,140 | 2,988 | $34.65 | $27.13 |
States with the most Q2052 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Florida | 43,266 | $25.47 |
| California | 31,650 | $27.27 |
| Texas | 24,591 | $26.52 |
| Massachusetts | 23,652 | $26.41 |
| Pennsylvania | 21,219 | $24.44 |
Medicare policy articles for this code
- A52509: Intravenous Immune Globulin - Policy Article (CGS Administrators, LLC (DME MAC) Noridian Healthcare Solutions, LLC (DME MAC)) — mentions this code in its coding guidance
Covered diagnoses (25 ICD-10-CM codes)
The diagnoses most often listed as covered in the policy articles above:
| ICD-10-CM | Diagnosis | Articles listing it |
|---|---|---|
| D80.0 | Hereditary hypogammaglobulinemia | 1 |
| D80.2 | Selective deficiency of immunoglobulin A [IgA] | 1 |
| D80.3 | Selective deficiency of immunoglobulin G [IgG] subclasses | 1 |
| D80.4 | Selective deficiency of immunoglobulin M [IgM] | 1 |
| D80.5 | Immunodeficiency with increased immunoglobulin M [IgM] | 1 |
| D80.6 | Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinemia | 1 |
| D80.7 | Transient hypogammaglobulinemia of infancy | 1 |
| D81.0 | Severe combined immunodeficiency [SCID] with reticular dysgenesis | 1 |
| D81.1 | Severe combined immunodeficiency [SCID] with low T- and B-cell numbers | 1 |
| D81.2 | Severe combined immunodeficiency [SCID] with low or normal B-cell numbers | 1 |
Showing 10 of 25. The full list, non-covered diagnoses and CSV export are in Caduvo.
What changed for Q2052
- 2014-04-01: Q2052 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code Q2052?
Q2052 is the HCPCS Level II code for services, supplies and accessories used in the home for the administration of intravenous immune globulin (IVIG). Short descriptor: "Home ivig, services/supplies".
How much does Medicare pay for Q2052?
In 2024, the average Medicare payment was $27.13 per service (average allowed $34.65).
Does Medicare cover Q2052?
Coverage code D — Special coverage instructions apply. Medicare covers it when its national or local coverage criteria are met.
Which diagnoses support coverage for Q2052?
Medicare policy articles that cite Q2052 list 25 covered ICD-10-CM diagnosis codes across 1 article. The most cited include D80.0 (Hereditary hypogammaglobulinemia), D80.2 (Selective deficiency of immunoglobulin A [IgA]), D80.3 (Selective deficiency of immunoglobulin G [IgG] subclasses). A listed diagnosis is necessary but not sufficient; the policy's other criteria still apply.
Related Q20 codes
- Q2004 — Irrigation solution for treatment of bladder calculi, for example renacidin, per 500 ml
- Q2009 — Injection, fosphenytoin, 50 mg phenytoin equivalent
- Q2017 — Injection, teniposide, 50 mg
- Q2026 — Injection, radiesse, 0.1 ml
- Q2028 — Injection, sculptra, 0.5 mg
- Q2034 — Influenza virus vaccine, split virus, for intramuscular use (agriflu)
- Q2035 — Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (afluria)
- Q2036 — Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval)
- Q2037 — Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin)
- Q2038 — Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone)
- Q2039 — Influenza virus vaccine, not otherwise specified
- Q2040 — Tisagenlecleucel, up to 250 million car-positive viable t cells, including leukapheresis and dose preparation procedures, per infusion
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under Q2052
- Watch Q2052 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for Q2052
Sources: CMS HCPCS Level II release October 2025; CMS DMEPOS fee schedule; CMS NCCI MUE tables; CMS Medicare utilization (physician and DME supplier files); CMS Medicare Coverage Database articles. Fees are Medicare allowables, not commercial rates. Not billing or legal advice.